[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609328":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":45,"centralContacts":50,"locations":56,"responsibleParty":85,"collaborators":88,"id":92,"slug":93,"hasResults":94,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":54,"eligibilityCriteria":98,"healthyVolunteers":94,"sex":99,"minAge":100,"maxAge":54,"enrollmentInfo":101,"targetDuration":54,"studyType":104,"phases":105,"briefSummary":107,"conditions":108,"keywords":54,"overallStatus":59,"whyStopped":54,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},{"fullName":5,"class":6},"Emory University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group I (qOBM)","EXPERIMENTAL","Patients who have skin melanoma and\u002For suspected dysplastic nevi undergo qOBM optical imaging scan on study. Patients may undergo 2 additional qOBM optical imaging scans at the discretion of the treating physician. After qOBM scans, patients who are diagnosed with skin cancer may proceed to Group II.",[13],"Procedure: Quantitative Oblique Back-Illumination Microscopy",{"label":15,"type":10,"description":16,"interventionNames":17},"Group II (qOBM, SOC RT)","GROUP II: Patients with skin cancer who are undergoing SOC RT undergo qOBM optical imaging scans prior to- and during or after SOC RT on study. Patients may also undergo qOBM optical imaging scans additional at approximately 1, 6, and 12 months after completion of SOC RT at the discretion of the treating physician.",[13,18],"Radiation: Radiation Therapy",[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","Quantitative Oblique Back-Illumination Microscopy","Undergo qOBM",[9,15],[26],"qOBM",{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"RADIATION","Radiation Therapy","Undergo SOC RT",[15],[33,34,35,36,37,38,39,40,41,42,43,44],"Cancer Radiotherapy","Energy Type","ENERGY_TYPE","Irradiate","Irradiated","Irradiation","Radiation","Radiation Therapy, NOS","Radiotherapeutics","Radiotherapy","RT","Therapy, Radiation",[46],{"name":47,"affiliation":48,"role":49},"Mohammad K. Khan, MD, PhD, MS, FACRO, FACR, DABR","Emory University Hospital\u002FWinship Cancer Institute","PRINCIPAL_INVESTIGATOR",[51],{"name":47,"role":52,"phone":53,"phoneExt":54,"email":55},"CONTACT","404-778-3473",null,"m.k.khan@emory.edu",[57,76],{"facility":58,"status":59,"city":60,"state":61,"zip":62,"country":63,"countryCode":64,"cosmosGeoPoint":65,"geoPoint":70,"contacts":71},"Emory University Hospital Midtown","RECRUITING","Atlanta","Georgia","30308","United States","US",{"type":66,"coordinates":67},"Point",[68,69],-84.38798,33.749,{"lat":69,"lon":68},[72,75],{"name":73,"role":52,"phone":54,"phoneExt":54,"email":74},"Tiffaney Roundtree","tiffaney.laquinta.roundtree@emory.edu",{"name":47,"role":49,"phone":54,"phoneExt":54,"email":54},{"facility":48,"status":59,"city":60,"state":61,"zip":77,"country":63,"countryCode":64,"cosmosGeoPoint":78,"geoPoint":80,"contacts":81},"30322",{"type":66,"coordinates":79},[68,69],{"lat":69,"lon":68},[82,84],{"name":83,"role":52,"phone":54,"phoneExt":54,"email":74},"Tiffaney K. Roundtree",{"name":47,"role":49,"phone":54,"phoneExt":54,"email":54},{"type":49,"investigatorFullName":86,"investigatorTitle":87,"investigatorAffiliation":5,"oldNameTitle":54,"oldOrganization":54},"Mohammad K. Khan","Principal Investigator",[89],{"name":90,"class":91},"National Cancer Institute (NCI)","NIH","100609328","optical-imaging-scans-for-the-diagnosis-of-skin-cancer-in-patients-with-lesions-100609328",false,"NCT07213154","Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions","Assessment of Novel Label-free Optical Imaging Technology for the Evaluation of Skin Lesions","Inclusion Criteria:\n\n* Male or Female\n* Candidate with skin lesions\n* Signed study-specific informed consent prior to study entry\n* ≥ 18 years old\n\nExclusion Criteria:\n\n* Prior surgery or radiotherapy to the area to be treated","ALL","18 Years",{"count":102,"type":103},10,"ESTIMATED","INTERVENTIONAL",[106],"NA","This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.",[109,110,111],"Malignant Skin Neoplasm","Skin Disorder","Skin Neoplasm","2025-12-11",{"date":114,"type":115},"2025-12-16","ACTUAL",{"date":117,"type":115},"2025-10-15",{"date":119,"type":103},"2027-09-17",{"name":5,"class":6},2]